A61K 51/0451
Having four such rings
Official title: {having four such rings, e.g. phorphine derivatives, bilirubin, biliverdine (hemin, hematin A61K51/0472)}
A61K51/0451 (Having four such rings) appears on 7 US grants and 10 published applications in this corpus.
Search patents in A61K- Granted patents
- 7
- Published applications
- 10
- Assignees
- 13
- Inventors
- 17
- Latest grant
- 25 Feb 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 2 | 3 |
| 2014 | 3 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
By publication year.
Recent patents
- Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles25 Feb 2020US 10,568,963 B2He Research Foundation of State University of New York
- PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded9 Dec 2014US 8,906,343 B2Health Research, Inc.
- RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors26 Aug 2014US 8,815,213 B2Yeda Research and Development Co. Ltd.
- Compound containing a carbon or an oxygen isotope, preparation and use thereof, and composition comprising thereof29 Apr 2014US 8,709,381 B2Beijing Top Grade Medical Equipment Co., Ltd.
- PAA nanoparticles for enhancement of tumor imaging22 Oct 2013US 8,562,944 B2Health Research, Inc.
- Pharmaceutical formulations and methods for delivering a therapeutic, diagnostic, or imaging agent to cd20618 Aug 2022US 2022/0257805 A1Syracuse University
- Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles8 Aug 2013US 2013/0202525 A1Health Research, Inc.
- Paa nanoparticles for pet imaging and pdt treatment8 Aug 2013US 2013/0202526 A1Health Research, Inc.
- Paa nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded1 Aug 2013US 2013/0195758 A1Health Research, Inc.
- Compound containing a carbon or an oxygen isotope, preparation and use thereof, and composition comprising thereof3 May 2012US 2012/0107238 A1Beijing Top Grade Medical Equipment Co., Ltd.
Most cited
By later US patents
- Porphyrazine optical and dual optical/MR contrast and therapeutic agents54US 8,540,967 B2Hoffman/Barrett, L.L.C. · 2013
- Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis10US 6,906,050 B2Miravant Pharmaceuticals, Inc. · 2005
- PAA nanoparticles for enhancement of tumor imaging4US 8,562,944 B2Health Research, Inc. · 2013
- PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded3US 8,906,343 B2Health Research, Inc. · 2014
- RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors2US 8,815,213 B2Yeda Research and Development Co. Ltd. · 2014